This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cytori Therapeutics Inc (CYTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 15.51M 25.72M 36.92M 52.67M
Receivables 4.15M 3.93M 2.26M 2.07M
Inventories 3.69M 3.18M 3.32M 3.38M
Other Current Assets 1.22M 1.16M 837.00K 834.00K
Total Current Assets 24.58M 33.98M 43.34M 58.95M
Property, Plant & Equipment, Gross 10.60M 10.78M 9.70M 9.30M
Accumulated Depreciation & Depletion 9.55M 8.61M 7.99M 7.61M
Property, Plant & Equipment, Net 1.05M 2.17M 1.71M 1.68M
Intangibles 9.34M 0.00 192.00K 413.00K
Other Non-Current Assets 3.16M 3.18M 2.37M 1.38M
Total Non-Current Assets 17.48M 9.27M 8.20M 7.39M
Liabilities & Shareholder Equity
Total Assets 42.06M 43.25M 51.53M 66.35M
Accounts Payable 965.00K 1.58M 272.00K 6.77M
Short Term Debt 3.19M 9.78M 2.49M 6.45M
Other Current Liabilities 5.64M 418.00K 0.00 0.00
Total Current Liabilities 14.91M 17.61M 7.82M 13.22M
Long Term Debt 23.10M 12.90M 21.96M 0.00
Deferred Income Taxes 710.00K 0.00 0.00 0.00
Other Non-Current Liabilities 212.00K 6.28M 11.80M 17.00M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 24.02M 19.18M 33.77M 30.25M
Total Liabilities 38.93M 36.80M 41.59M 43.47M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 3.13M 6.46M 9.95M 22.87M
Common Par 71.00K 66.00K 57.00K 52.00K
Additional Paid In Capital 303.71M 281.12M 252.34M 232.82M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -300.90M -274.73M -242.45M -210.00M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 256.00K 0.00 0.00 0.00
Total Capitalization 26.23M 19.36M 31.91M 22.87M
Total Equity 3.13M 6.46M 9.95M 22.87M
Total Liabilities & Stock Equity 42.06M 43.25M 51.53M 66.35M
Total Common Shares Outstanding 71.31M 65.91M 56.59M 51.96M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 67.78M 58.68M 53.50M 45.95M
Diluted Weighted Shares Outstanding 67.78M 58.68M 53.50M 45.95M
Number of Employees 115 127 128 124
Number of Part-Time Employees 0 0 0 0
CYTX News

CYTX Cytori Therapeutics Inc

Analysts Ratings for CYTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CYTX ANALYST REPORT

Brokerage Partners

CYTX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs